Paysign, Inc. Applauds Preliminary Injunction of Plasma Ban

Stock Information for Paysign Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Paysign Inc.

Paysign to Host First Quarter 2024 Earnings Call
Paysign, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results
Paysign, Inc. to Sponsor the 2024 International Plasma Protein Congress April 16-17
Paysign, Inc. Reinforces Payment Processing Acumen With New Executive Hire
Paysign, Inc. to Sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29
Paysign Inc. to Sponsor the 2024 ACCESS USA Conference March 19-21
Paysign to Host Fourth Quarter and Full Year 2023 Earnings Call
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc. - PAYS

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.